A review of all available data at this time shows that the J&J/Janssen COVID-19 vaccine’s known and potential benefits outweigh its known and potential risks. 2019 Novel Coronavirus

  Last week, Vanderbilt University Medical Center announced that COVID-19 vaccinations for leaders will become required. This was a carefully considered step forward in VUMC’s ongoing efforts to protect...

Delta is currently the predominant strain of the virus in the United States. The Delta variant causes more infections and spreads faster than early forms SARS-CoV-2. 2019 Novel Coronavirus

  by Jessica Pasley As the more contagious delta variant of COVID-19 spreads, impacting children, pediatricians at Monroe Carell Jr. Children’s Hospital at Vanderbilt say there are steps parents...

People who have had 2 shots of Pfizer-BioNTech or Moderna vaccines may need to start receiving a COVID-19 booster shot 8 months after their second dose. 2019 Novel Coronavirus

  by Paul Govern Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked...

by Bill Snyder A monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca reduced the risk of symptoms in a study...

Although the vaccine supply is currently limited, CDC is working toward making vaccines widely available for everyone at no cost. Learn more about your state’s plan. 2019 Novel Coronavirus

Translated COVID-19 prevention messages for migrants, refugees, and other limited-English-proficient populations, to reach them in their native languages. 2019 Novel Coronavirus

COVID-19 vaccines authorized for use in the U.S. are working well based on studies that have looked at how vaccines work in real-world conditions. 2019 Novel Coronavirus